Ensenyat-Mendez, M., Rünger, D., Orozco, J. I. J., Le, J., Baker, J. L., Weidhaas, J., … DiNome, M. L. (2022). ASO Visual Abstract: Epigenetic Signatures Predict Pathologic Nodal Stage in Breast Cancer Patients with Estrogen-Receptor-Positive, Clinically Node-Positive Disease. Ann Surg Oncol. https://doi.org/10.1245/s10434-022-11744-5

Ensenyat-Mendez, Miquel, Dennis Rünger, Javier I. J. Orozco, Julie Le, Jennifer L. Baker, Joanne Weidhaas, Diego M. Marzese, and Maggie L. DiNome. “ASO Visual Abstract: Epigenetic Signatures Predict Pathologic Nodal Stage in Breast Cancer Patients with Estrogen-Receptor-Positive, Clinically Node-Positive Disease.” Ann Surg Oncol, April 16, 2022. https://doi.org/10.1245/s10434-022-11744-5.

Ensenyat-Mendez M, Rünger D, Orozco JIJ, Le J, Baker JL, Weidhaas J, et al. ASO Visual Abstract: Epigenetic Signatures Predict Pathologic Nodal Stage in Breast Cancer Patients with Estrogen-Receptor-Positive, Clinically Node-Positive Disease. Ann Surg Oncol. 2022 Apr 16;

Ensenyat-Mendez, Miquel, et al. “ASO Visual Abstract: Epigenetic Signatures Predict Pathologic Nodal Stage in Breast Cancer Patients with Estrogen-Receptor-Positive, Clinically Node-Positive Disease.” Ann Surg Oncol, Apr. 2022. Pubmed, doi:10.1245/s10434-022-11744-5.

Ensenyat-Mendez M, Rünger D, Orozco JIJ, Le J, Baker JL, Weidhaas J, Marzese DM, DiNome ML. ASO Visual Abstract: Epigenetic Signatures Predict Pathologic Nodal Stage in Breast Cancer Patients with Estrogen-Receptor-Positive, Clinically Node-Positive Disease. Ann Surg Oncol. 2022 Apr 16;